RATIONALE: Existing trials of adjunctive vitamin D in the treatment of pulmonary tuberculosis (PTB) are variously limited by small sample sizes, inadequate dosing regimens, and high baseline vitamin D status among participants. Comprehensive analyses of the effects of genetic variation in the vitamin D pathway on response to vitamin D supplementation are lacking. OBJECTIVES: To determine the effect of high-dose vitamin D3 on response to antimicrobial therapy for PTB and to evaluate the influence of single-nucleotide polymorphisms (SNPs) in vitamin D pathway genes on response to adjunctive vitamin D3. METHODS: We conducted a clinical trial in 390 adults with PTB in Ulaanbaatar, Mongolia, who were randomized to receive four biweekly doses of 3.5 mg (140,000 IU) vitamin D3 (n = 190) or placebo (n = 200) during intensive-phase antituberculosis treatment. MEASUREMENTS AND MAIN RESULTS: The intervention elevated 8-week serum 25-hydroxyvitamin D concentrations (154.5 nmol/L vs. 15.2 nmol/L in active vs. placebo arms, respectively; 95% confidence interval for difference, 125.9-154.7 nmol/L; P < 0.001) but did not influence time to sputum culture conversion overall (adjusted hazard ratio, 1.09; 95% confidence interval, 0.86-1.36; P = 0.48). Adjunctive vitamin D3 accelerated sputum culture conversion in patients with one or more minor alleles for SNPs in genes encoding the vitamin D receptor (rs4334089, rs11568820) and 25-hydroxyvitamin D 1α-hydroxylase (CYP27B1: rs4646536) (adjusted hazard ratio ≥ 1.47; P for interaction ≤ 0.02). CONCLUSIONS: Vitamin D3 did not influence time to sputum culture conversion in the study population overall. Effects of the intervention were modified by SNPs in VDR and CYP27B1. Clinical trial registered with www.clinicaltrials.gov (NCT01657656).
RCT Entities:
RATIONALE: Existing trials of adjunctive vitamin D in the treatment of pulmonary tuberculosis (PTB) are variously limited by small sample sizes, inadequate dosing regimens, and high baseline vitamin D status among participants. Comprehensive analyses of the effects of genetic variation in the vitamin D pathway on response to vitamin D supplementation are lacking. OBJECTIVES: To determine the effect of high-dose vitamin D3 on response to antimicrobial therapy for PTB and to evaluate the influence of single-nucleotide polymorphisms (SNPs) in vitamin D pathway genes on response to adjunctive vitamin D3. METHODS: We conducted a clinical trial in 390 adults with PTB in Ulaanbaatar, Mongolia, who were randomized to receive four biweekly doses of 3.5 mg (140,000 IU) vitamin D3 (n = 190) or placebo (n = 200) during intensive-phase antituberculosis treatment. MEASUREMENTS AND MAIN RESULTS: The intervention elevated 8-week serum 25-hydroxyvitamin D concentrations (154.5 nmol/L vs. 15.2 nmol/L in active vs. placebo arms, respectively; 95% confidence interval for difference, 125.9-154.7 nmol/L; P < 0.001) but did not influence time to sputum culture conversion overall (adjusted hazard ratio, 1.09; 95% confidence interval, 0.86-1.36; P = 0.48). Adjunctive vitamin D3 accelerated sputum culture conversion in patients with one or more minor alleles for SNPs in genes encoding the vitamin D receptor (rs4334089, rs11568820) and 25-hydroxyvitamin D 1α-hydroxylase (CYP27B1: rs4646536) (adjusted hazard ratio ≥ 1.47; P for interaction ≤ 0.02). CONCLUSIONS:Vitamin D3 did not influence time to sputum culture conversion in the study population overall. Effects of the intervention were modified by SNPs in VDR and CYP27B1. Clinical trial registered with www.clinicaltrials.gov (NCT01657656).
Authors: Nestan Tukvadze; Ekaterina Sanikidze; Maia Kipiani; Gautam Hebbar; Kirk A Easley; Neeta Shenvi; Russell R Kempker; Jennifer K Frediani; Veriko Mirtskhulava; Jessica A Alvarez; Nino Lomtadze; Lamara Vashakidze; Li Hao; Carlos Del Rio; Vin Tangpricha; Henry M Blumberg; Thomas R Ziegler Journal: Am J Clin Nutr Date: 2015-09-23 Impact factor: 7.045
Authors: Sreeram V Ramagopalan; Andreas Heger; Antonio J Berlanga; Narelle J Maugeri; Matthew R Lincoln; Amy Burrell; Lahiru Handunnetthi; Adam E Handel; Giulio Disanto; Sarah-Michelle Orton; Corey T Watson; Julia M Morahan; Gavin Giovannoni; Chris P Ponting; George C Ebers; Julian C Knight Journal: Genome Res Date: 2010-08-24 Impact factor: 9.043
Authors: David A Jolliffe; Robert T Walton; Christopher J Griffiths; Adrian R Martineau Journal: J Steroid Biochem Mol Biol Date: 2015-12-11 Impact factor: 4.292
Authors: Adrian R Martineau; Friedemann U Honecker; Robert J Wilkinson; Christopher J Griffiths Journal: J Steroid Biochem Mol Biol Date: 2007-01-12 Impact factor: 4.292
Authors: Christopher R Sudfeld; Ferdinand Mugusi; Said Aboud; Tumaini J Nagu; Molin Wang; Wafaie W Fawzi Journal: Trials Date: 2017-02-10 Impact factor: 2.279
Authors: Adrian R Martineau; David A Jolliffe; Richard L Hooper; Lauren Greenberg; John F Aloia; Peter Bergman; Gal Dubnov-Raz; Susanna Esposito; Davaasambuu Ganmaa; Adit A Ginde; Emma C Goodall; Cameron C Grant; Christopher J Griffiths; Wim Janssens; Ilkka Laaksi; Semira Manaseki-Holland; David Mauger; David R Murdoch; Rachel Neale; Judy R Rees; Steve Simpson; Iwona Stelmach; Geeta Trilok Kumar; Mitsuyoshi Urashima; Carlos A Camargo Journal: BMJ Date: 2017-02-15
Authors: Anna P Ralph; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Andri Wiguna; Emiliana Tjitra; Dina B Lolong; Tsin W Yeo; Mark D Chatfield; Retno K Soemanto; Ivan Bastian; Richard Lumb; Graeme P Maguire; John Eisman; Ric N Price; Peter S Morris; Paul M Kelly; Nicholas M Anstey Journal: PLoS One Date: 2013-08-14 Impact factor: 3.240
Authors: Stefan Bittner; Sinah Engel; Christoph Lange; Martin S Weber; Aiden Haghikia; Felix Luessi; Thomas Korn; Luisa Klotz; Antonios Bayas; Friedemann Paul; Christoph Heesen; Martin Stangel; Brigitte Wildemann; Florian Then Bergh; Björn Tackenberg; Corinna Trebst; Clemens Warnke; Ralf Linker; Martin Kerschensteiner; Uwe Zettl; Hayrettin Tumani; Wolfgang Brück; Sven G Meuth; Tanja Kümpfel; Bernhard Hemmer; Heinz Wiendl; Ralf Gold; Frauke Zipp Journal: Nervenarzt Date: 2019-12 Impact factor: 1.214
Authors: A Bekele; N Gebreselassie; S Ashenafi; E Kassa; G Aseffa; W Amogne; M Getachew; A Aseffa; A Worku; R Raqib; B Agerberth; U Hammar; P Bergman; G Aderaye; J Andersson; S Brighenti Journal: J Intern Med Date: 2018-05-23 Impact factor: 8.989
Authors: Daniel E Roth; Steven A Abrams; John Aloia; Gilles Bergeron; Megan W Bourassa; Kenneth H Brown; Mona S Calvo; Kevin D Cashman; Gerald Combs; Luz María De-Regil; Maria Elena Jefferds; Kerry S Jones; Hallie Kapner; Adrian R Martineau; Lynnette M Neufeld; Rosemary L Schleicher; Tom D Thacher; Susan J Whiting Journal: Ann N Y Acad Sci Date: 2018-09-18 Impact factor: 5.691
Authors: Juliane Radloff; Jan Heyckendorf; Lize van der Merwe; Patricia Sanchez Carballo; Norbert Reiling; Elvira Richter; Christoph Lange; Barbara Kalsdorf Journal: Front Immunol Date: 2018-07-24 Impact factor: 7.561